Publications

Economic model to examine the cost-effectiveness of FlowOx home therapy compared to standard care in patients with peripheral artery disease.

2021
Ezeofor, V. S., Bray, N., Bryning, L., Hashmi, F., Hoel, H., Parker, D., & Edwards, R. T. (2021). Economic model to examine the cost-effectiveness of FlowOx home therapy compared to standard care in patients with peripheral artery disease. PLoS ONE, 16(1 January), 1–20.